Assessment of women's treatment preferences for vasomotor symptoms due to menopause.
Aki ShiozawaRebecca C ThurstonErin CookHongbo YangDeanna D KingRita M KristyShayna MancusoPublished in: Expert review of pharmacoeconomics & outcomes research (2023)
Sleep improvement and reductions in VMS frequency/severity were the most important treatment attributes.